Cart
sales@molnova.com
AZ960
CAS No. 905586-69-8
AZ960( AZ-960 | AZ 960 )
Catalog No. M16510 CAS No. 905586-69-8
A potent, selective JAK2 inhibitor with Ki of 0.45 nM, IC50 of <3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 74 | In Stock |
|
| 5MG | 113 | In Stock |
|
| 10MG | 186 | In Stock |
|
| 25MG | 344 | In Stock |
|
| 50MG | 511 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAZ960
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective JAK2 inhibitor with Ki of 0.45 nM, IC50 of <3 nM.
-
DescriptionA potent, selective JAK2 inhibitor with Ki of 0.45 nM, IC50 of <3 nM; displays 3-fold selectivity over JAK3 (IC50=9 nM); blocks STAT5 phosphorylation and potently inhibits cell proliferation (GI50=25 nM) in TEL-JAK2 driven Ba/F3 cells, blocks BCL-XL, PIM1 and PIM2 mRNA expression and induces apoptosis; also induces growth arrest and apoptosis in adult T-cell leukemia cells; also inhibits parasite Trypanosoma brucei ERK8 (Ki=1.25 uM) with antiparasitic activity (IC50=120nM).Blood Cancer Preclinical.
-
In Vitro——
-
In Vivo——
-
SynonymsAZ-960 | AZ 960
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK2| JAK2
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number905586-69-8
-
Formula Weight354.3566464
-
Molecular FormulaC18H16F2N6
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESN#CC1=C(N[C@H](C2=CC=C(F)C=C2)C)N=C(NC3=NNC(C)=C3)C(F)=C1
-
Chemical Name3-Pyridinecarbonitrile, 5-fluoro-2-[[(1S)-1-(4-fluorophenyl)ethyl]amino]-6-[(5-methyl-1H-pyrazol-3-yl)amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gozgit JM, et al. J Biol Chem. 2008 Nov 21;283(47):32334-43.
2. Yang J, et al. Mol Cancer Ther. 2010 Dec;9(12):3386-95.
3. Valenciano AL, et al. Bioorg Med Chem. 2016 Oct 1;24(19):4647-4651.
molnova catalog
related products
-
TG-46
TG-46 (TG46) inhibits JAK2, FLT3, RET, JAK3 and can be used to study glaucoma.
-
JAK2-IN-7
JAK2-IN-7 is a selective JAK2 inhibitor with IC50s of 3, 11.7, and 41 nM for JAK2, SET-2, and Ba/F3V617F cells, respectively. JAK2-IN-7 possesses >14-fold selectivity over JAK1, JAK3, FLT3. JAK2-IN-7 stimulates cell cycle arrest in the G0/G1 phase and induces tumor cellapoptosis. Antitumor activities.
-
PF-956980
A potent, highly specific JAK3 inhibitor with IC50 of 4 nM; shows only modest inhibition of PKA (6.7 uM) and LCK (10.9 uM) in vitro.
